<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="06/04/2006" creator="Noriko Katsu" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=1981844">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>1981844</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term sem="Other" id="T1" lex="human_immunodeficiency_virus_type-2_gene_expression"><term sem="DNA_domain_or_region" id="A5"><term sem="Virus" id="T2" lex="human_immunodeficiency_virus_type-2"><term sem="Virus" id="T3" lex="human_immunodeficiency_virus">Human immunodeficiency virus</term> type-2</term> gene</term> expression</term>: two <term sem="DNA_domain_or_region" id="T4" lex="enhancer">enhancers</term> and their activation by <term sem="Other" id="T5" lex="T-cell_activator"><term sem="Cell_natural" id="T6" lex="T-cell">T-cell</term> activators</term>.</sentence>
<event id="E1">
<type class="Gene_expression" />
<theme idref="A5" />
<clue>Human immunodeficiency virus type-2 gene <clueType>expression</clueType>: two enhancers and their activation by T-cell activators.</clue>
</event>
<event id="E2">
<type class="Positive_regulation" />
<theme idref="T4" />
<cause idref="T5" />
<clue>Human immunodeficiency virus type-2 gene expression: two enhancers and their <clueType>activation</clueType> <linkCause>by</linkCause> T-cell activators.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The <term sem="Virus" id="T7" lex="human_immunodeficiency_virus">human immunodeficiency viruses</term> (<term sem="Virus" id="T8" lex="HIV">HIVs</term>) may include a spectrum of <term sem="Virus" id="T9" lex="retrovirus">retroviruses</term> with varying potential to infect their <term sem="Multicellular_organism_natural" id="A1">host</term>, undergo long periods of <term sem="Other" id="T10" lex="latent_infection">latent infection</term>, and induce <term sem="Other" id="T11" lex="pathology">pathology</term>.</sentence>
<event id="E3">
<type class="Initiation_of_viral_infection" />
<theme idref="A1" />
<theme idref="T8" />
<clue>The human immunodeficiency viruses (HIVs) may include a spectrum of retroviruses with varying potential to <clueType>infect</clueType> their host, undergo long periods of latent infection, and induce pathology.</clue>
</event>
<event id="E20">
<type class="Positive_regulation" />
<theme idref="T10" />
<cause idref="T8" />
<clue>The human immunodeficiency viruses (HIVs) may include a spectrum of retroviruses with varying potential to infect their host, <clueType>undergo</clueType> long periods of latent infection, and induce pathology.</clue>
</event>
<event id="E21">
<type class="Positive_regulation" />
<theme idref="T11" />
<cause idref="T8" />
<clue>The human immunodeficiency viruses (HIVs) may include a spectrum of retroviruses with varying potential to infect their host, undergo long periods of latent infection, and <clueType>induce</clueType> pathology.</clue>
</event>
<sentence id="S3">Since expression of the <term sem="DNA_domain_or_region" id="A2">viruses</term> is in large part regulated by the <term sem="DNA_domain_or_region" id="T12" lex="sequence_element">sequence elements</term> in their <term sem="DNA_domain_or_region" id="T13" lex="long_terminal_repeat">long terminal repeats</term> (<term sem="DNA_domain_or_region" id="T14" lex="LTR">LTRs</term>), this study was directed to an analysis of the <term sem="DNA_family_or_group" id="T15" lex="regulatory_element">regulatory elements</term> in the <term sem="DNA_domain_or_region" id="T16" lex="HIV-2_LTR"><term sem="Virus" id="T17" lex="HIV-2">HIV-2</term> LTR</term>.</sentence>
<event id="E4">
<type class="Gene_expression" />
<theme idref="A2" />
<clue>Since <clueType>expression</clueType> <linkTheme>of</linkTheme> the viruses is in large part regulated by the sequence elements in their long terminal repeats (LTRs), this study was directed to an analysis of the regulatory elements in the HIV-2 LTR.</clue>
</event>
<event id="E5">
<type class="Regulation" />
<theme idref="E4" />
<cause idref="T14" />
<clue>Since expression of the viruses is in large part <clueType>regulated</clueType> <linkCause>by</linkCause> the sequence elements in their long terminal repeats (LTRs), this study was directed to an analysis of the regulatory elements in the HIV-2 LTR.</clue>
</event>
<sentence id="S4">The <term sem="DNA_domain_or_region" id="T18" lex="HIV-2_LTR"><term sem="Virus" id="T19" lex="HIV-2">HIV-2</term> LTR</term> was found to contain two <term sem="DNA_domain_or_region" id="T20" lex="enhancer">enhancers</term>.</sentence>
<sentence id="S5">One of these <term sem="DNA_domain_or_region" id="T21" lex="enhancer">enhancers</term> is, in part, identical to the <term sem="DNA_domain_or_region" id="T22" lex="HIV-1_enhancer"><term sem="Virus" id="T23" lex="HIV-1">HIV-1</term> enhancer</term>.</sentence>
<sentence id="S6">This <term sem="DNA_domain_or_region" id="T24" lex="enhancer">enhancer</term> in <term sem="Virus" id="T25" lex="HIV-1">HIV-1</term> is the <term sem="DNA_domain_or_region" id="T26" lex="T-cell_activation_response_element"><term sem="Other" id="T27" lex="T-cell_activation"><term sem="Cell_natural" id="A6">T-cell</term> activation</term> response element</term>; in <term sem="Virus" id="T28" lex="HIV-2">HIV-2</term>, however, it is the <term sem="DNA_domain_or_region" id="T29" lex="second_enhancer">second enhancer</term> that is mainly responsible for activation in response to <term sem="Other" id="T30" lex="T-cell_activator">T-cell activators</term>.</sentence>
<event id="E7">
<type class="Physiological_process" />
<theme idref="A6" />
<cause idref="T30" />
<clue>This enhancer in HIV-1 is the T-cell activation response element; in HIV-2, however, it is the second enhancer that is mainly responsible for <clueType>activation</clueType> <linkCause>in response to</linkCause> T-cell activators.</clue>
</event>
<event id="E8">
<type class="Regulation" />
<theme idref="E7" />
<cause idref="T29" />
<clue>This enhancer in HIV-1 is the T-cell activation response element; <clueLoc>in HIV-2</clueLoc>, however, it is the second enhancer that is mainly <clueType>responsible</clueType> <linkTheme>for</linkTheme> activation in response to T-cell activators.</clue>
</event>
<sentence id="S7">The second <term sem="DNA_domain_or_region" id="T31" lex="enhancer">enhancer</term> interacts with two <term sem="Protein_family_or_group" id="T32" lex="nuclear_binding_protein">nuclear binding proteins</term> (<term sem="Protein_family_or_group" id="A3">85 kD</term> and <term sem="Protein_family_or_group" id="A4">27 kD</term> mobility) that appear to be required for optimal <term sem="Other" id="T33" lex="enhancer_function">enhancer function</term> and activation.</sentence>
<event uncertainty="probable" id="E9">
<type class="Positive_regulation" />
<theme idref="T33" />
<cause idref1="T32" idref="A3" />
<clue>The second enhancer interacts with two nuclear binding proteins (85 kD and 27 kD mobility) that appear to be <clueType>required</clueType> <linkTheme>for</linkTheme> optimal enhancer function and activation.</clue>
</event>
<event uncertainty="probable" id="E10">
<type class="Positive_regulation" />
<theme idref="E11" />
<cause idref1="T32" idref="A3" />
<clue>The second enhancer interacts with two nuclear binding proteins (85 kD and 27 kD mobility) that appear to be <clueType>required</clueType> <linkTheme>for</linkTheme> optimal enhancer function and activation.</clue>
</event>
<event id="E11">
<type class="Positive_regulation" />
<theme idref="T31" />
<clue>The second enhancer interacts with two nuclear binding proteins (85 kD and 27 kD mobility) that appear to be required for optimal enhancer function and <clueType>activation</clueType>.</clue>
</event>
<event uncertainty="probable" id="E12">
<type class="Positive_regulation" />
<theme idref="T33" />
<cause idref1="T32" idref="A4" />
<clue>The second enhancer interacts with two nuclear binding proteins (85 kD and 27 kD mobility) that appear to be <clueType>required</clueType> <linkTheme>for</linkTheme> optimal enhancer function and activation.</clue>
</event>
<event uncertainty="probable" id="E13">
<type class="Positive_regulation" />
<theme idref="E11" />
<cause idref1="T32" idref="A4" />
<clue>The second enhancer interacts with two nuclear binding proteins (85 kD and 27 kD mobility) that appear to be <clueType>required</clueType> <linkTheme>for</linkTheme> optimal enhancer function and activation.</clue>
</event>
<event id="E14">
<type class="Binding" />
<theme idref="T31" />
<theme idref1="T32" idref="A3" />
<clue>The second enhancer <clueType>interacts</clueType> <linkTheme>with</linkTheme> two nuclear binding proteins (85 kD and 27 kD mobility) that appear to be required for optimal enhancer function and activation.</clue>
</event>
<event id="E15">
<type class="Binding" />
<theme idref="T31" />
<theme idref1="T32" idref="A4" />
<clue>The second enhancer <clueType>interacts</clueType> <linkTheme>with</linkTheme> two nuclear binding proteins (85 kD and 27 kD mobility) that appear to be required for optimal enhancer function and activation.</clue>
</event>
<sentence id="S8">Observations such as these encourage the speculation that there may be subtle differences in the <term sem="Other" id="T34" lex="regulation">regulation</term> of <term sem="DNA_domain_or_region" id="A20"><term sem="Virus" id="T35" lex="HIV-1">HIV-1</term></term> and <term sem="Other" id="T36" lex="HIV-2_expression"><term sem="DNA_domain_or_region" id="A21"><term sem="Virus" id="T37" lex="HIV-2">HIV-2</term></term> expression</term> that may be relevant to the possible longer <term sem="Other" id="T38" lex="latency">latency</term> and reduced pathogenicity of <term sem="Virus" id="T39" lex="HIV-2">HIV-2</term>.</sentence>
<event id="E16">
<type class="Gene_expression" />
<theme idref="A20" />
<clue>Observations such as these encourage the speculation that there may be subtle differences in the regulation of HIV-1 and HIV-2 <clueType>expression</clueType> that may be relevant to the possible longer latency and reduced pathogenicity of HIV-2.</clue>
</event>
<event id="E17">
<type class="Gene_expression" />
<theme idref="A21" />
<clue>Observations such as these encourage the speculation that there may be subtle differences in the regulation of HIV-1 and HIV-2 <clueType>expression</clueType> that may be relevant to the possible longer latency and reduced pathogenicity of HIV-2.</clue>
</event>
<event id="E18">
<type class="Regulation" />
<theme idref="E16" />
<clue>Observations such as these encourage the speculation that there may be subtle differences in the <clueType>regulation</clueType> <linkTheme>of</linkTheme> HIV-1 and HIV-2 expression that may be relevant to the possible longer latency and reduced pathogenicity of HIV-2.</clue>
</event>
<event id="E19">
<type class="Regulation" />
<theme idref="E17" />
<clue>Observations such as these encourage the speculation that there may be subtle differences in the <clueType>regulation</clueType> <linkTheme>of</linkTheme> HIV-1 and HIV-2 expression that may be relevant to the possible longer latency and reduced pathogenicity of HIV-2.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
